Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy.

× No keyword cloud information.

22 in total

Review 1. Effects of fetal exposure to maternal chemotherapy.

Authors: Jana Dekrem; Kristel Van Calsteren; Frédéric Amant
Journal: Paediatr Drugs Date: 2013-10 Impact factor: 3.022

2. B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen.

Authors: Prakas Kumar Mandal; Tuphan Kanti Dolai; Basab Bagchi; Malay Kumar Ghosh; Sudipta Bose; Maitreyee Bhattacharyya
Journal: Indian J Pediatr Date: 2014-02-22 Impact factor: 1.967

3. Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire.

Authors: Amit Odelia; Joffe Erel; Perry Chava; Herishanu Yair; Sarid Nadav; Lishner Michael; Avivi Irit
Journal: Int J Clin Oncol Date: 2016-10-14 Impact factor: 3.402

Review 4. Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.

Authors: Ashima Makol; Kerry Wright; Shreyasee Amin
Journal: Drugs Date: 2011-10-22 Impact factor: 9.546

5. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.

Authors: Mario Ojeda-Uribe; Naji Afif; Etienne Dahan; Laetitia Sparsa; Celine Haby; Jean Sibilia; David Ternant; Marc Ardizzone
Journal: Clin Rheumatol Date: 2013-01-05 Impact factor: 2.980

6. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth.

Authors: Eun Ju Lee; Ki Hoon Ahn; Soon Cheol Hong; Eun Hee Lee; Yong Park; Byung Soo Kim
Journal: Obstet Gynecol Sci Date: 2014-11-20

Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy.

Review 1. Effects of fetal exposure to maternal chemotherapy.

2. B cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimen.

3. Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire.

Review 4. Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.

5. Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases.

6. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birth.

Review 7. [Biologics during pregnancy and breast--feeding].

Review 8. The use of biologics for autoimmune rheumatic diseases in fertility and pregnancy.

Review 9. To B or not to B cells-mediate a healthy start to life.

Review 10. Management of RA medications in pregnant patients.